Changes in Gray Matter Density in Fibromyalgia: Correlation With Dopamine Metabolism

Journal of Pain

Volumn 10, Issue 6, 2009, Pages 609-618

  Wood, Patrick B ^a   Glabus, Michael F ^a   Simpson, Ryan ^a   Patterson II, James C ^b  

^a LOUISIANA STATE UNIVERSITY HEALTH SCIENCES CENTER   (United States)

^b Louisiana State University School of Medicine Shreveport   (United States)

Author keywords

Cingulate cortex; dopamine; fibromyalgia; parahippocampal gyrus; pregenual cortex; voxel based morphometry

Indexed keywords

DOPAMINE;

ARTICLE; CINGULATE GYRUS; CLINICAL ARTICLE; CONTROLLED STUDY; CORRELATION ANALYSIS; DENSITY; DOPAMINE METABOLISM; FEMALE; FIBROMYALGIA; GRAY MATTER; HUMAN; LIMBIC CORTEX; MORPHOMETRICS; NERVE CELL; NUCLEAR MAGNETIC RESONANCE IMAGING; SUBICULUM; VENTRAL TEGMENTUM;

ADULT; ANALYSIS OF VARIANCE; BRAIN; CEREBRAL CORTEX; DIHYDROXYPHENYLALANINE; DOPAMINE; FEMALE; FIBROMYALGIA; HUMANS; MAGNETIC RESONANCE IMAGING; POSITRON-EMISSION TOMOGRAPHY;

EID: 67349118433     PISSN: 15265900     EISSN: 15288447     Source Type: Journal    
DOI: 10.1016/j.jpain.2008.12.008     Document Type: Article

References (68)

1. Adler G.K., and Geenen R. Hypothalamic-pituitary-adrenal and autonomic nervous system functioning in fibromyalgia. Rheum Dis Clin North Am 31 (2005) 187-202
2. Apkarian A.V., Sosa Y., Sonty S., Levy R.M., Harden R.N., Parrish T.B., and Gitelman D.R. Chronic back pain is associated with decreased prefrontal and thalamic gray matter density. J Neurosci 24 (2004) 10410-10415
3. Arnold L.M., Crofford L.J., Martin S.A., Young J.P., and Sharma U. The effect of anxiety and depression on improvements in pain in a randomized, controlled trial of pregabalin for treatment of fibromyalgia. Pain Med 8 (2007) 633-638
4. Bennett R.M., Jones J., Turk D.C., Russell I.J., and Matallana L. An internet survey of 2,596 people with fibromyalgia. BMC Musculoskelet Disord 8 (2007) 27
5. Boccardi M., Ghidoni R., Govoni S., Testa C., Benussi L., Bonetti M., Binetti G., and Frisoni G.B. Effects of hormone therapy on brain morphology of healthy postmenopausal women: A Voxel-based morphometry study. Menopause 13 (2006) 584-591
6. Bozzi Y., and Borrelli E. Dopamine D2 receptor signaling controls neuronal cell death induced by muscarinic and glutamatergic drugs. Mol Cell Neurosci 19 (2002) 263-271
7. Bozzi Y., Vallone D., and Borrelli E. Neuroprotective role of dopamine against hippocampal cell death. J Neurosci 20 (2000) 8643-8649
8. Bremner J.D., Elzinga B., Schmahl C., and Vermetten E. Structural and functional plasticity of the human brain in posttraumatic stress disorder. Prog Brain Res 167 (2008) 171-186
9. Buckner R.L., Andrews-Hanna J.R., and Schacter D.L. The brain's default network: Anatomy, function, and relevance to disease. Ann N Y Acad Sci 1124 (2008) 1-38
10. Carr D.B., and Sesack S.R. Projections from the rat prefrontal cortex to the ventral tegmental area: Target specificity in the synaptic associations with mesoaccumbens and mesocortical neurons. J Neurosci 20 (2000) 3864-3873
11. Chen S., Xia W., Li L., Liu J., He Z., Zhang Z., Yan L., Zhang J., and Hu D. Gray matter density reduction in the insula in fire survivors with posttraumatic stress disorder: A voxel-based morphometric study. Psychiatry Res 146 (2006) 65-72
12. Chua P., Krams M., Toni I., Passingham R., and Dolan R. A functional anatomy of anticipatory anxiety. Neuroimage 9 (1999) 563-571
13. Cook D.B., Lange G., Ciccone D.S., Liu W.C., Steffener J., and Natelson B.H. Functional imaging of pain in patients with primary fibromyalgia. J Rheumatol 31 (2004) 364-378
14. Critchley H.D., Mathias C.J., and Dolan R.J. Neural correlates of first and second-order representation of bodily states. Nat Neurosci 4 (2001) 207-212
15. Desgranges B., Baron J.C., and Eustache F. The functional neuroanatomy of episodic memory: The role of the frontal lobes, the hippocampal formation, and other areas. Neuroimage 8 (1998) 198-213
16. Diagnostic and Statistical Manual of Mental Disorders. 4th edition (DSM-IV) (1994), American Psychiatric Association Press, Washington, DC
17. Diorio D., Viau V., and Meaney M.J. The role of the medial prefrontal cortex (cingulate gyrus) in the regulation of hypothalamic-pituitary-adrenal responses to stress. J Neurosci 13 (1993) 3839-3847
18. Emad Y., Ragab Y., Zeinhom F., El-Khouly G., Abou-Zeid A., and Rasker J.J. Hippocampus dysfunction may explain symptoms of fibromyalgia syndrome: A study with single-voxel magnetic resonance spectroscopy. J Rheumatol 35 (2008) 1371-1377
19. Frankle W.G., Laruelle M., and Haber S.N. Prefrontal cortical projections to the midbrain in primates: Evidence for a sparse connection. Neuropsychopharmacology 31 (2006) 1627-1636
20. Fredrikson M., Furmark T., Olsson M.T., Fischer H., Andersson J., and Långström B. Functional neuroanatomical correlates of electrodermal activity: A positron emission tomographic study. Psychophysiology 35 (1998) 179-185
21. Gaser C: VBM2 Toolbox, version 1.06. Available at: http://dbm.neuro.uni-jena.de/
22. Giesecke T., Williams D.A., Harris R.E., Cupps T.R., Tian X., Tian T.X., Gracely R.H., and Clauw D.J. Subgrouping of fibromyalgia patients on the basis of pressure-pain thresholds and psychological factors. Arthritis Rheum 48 (2003) 2916-2922
23. Glabus MF, Hill AL, Featherstone L, Wood P: Brain structural abnormalities and their symptom correlates in fibromyalgia syndrome. Neuroimage 2004, CD-ROM. Proceedings of the 10th International Conference on Functional Mapping of the Human Brain. Poster TU 342 (Abstract)
24. Glass J.M. Fibromyalgia and cognition. J Clin Psychiatry 69 Suppl 2 (2008) 20-24
25. Glass J.M., Park D.C., Minear M., and Crofford L.J. Memory beliefs and function in fibromyalgia patients. J Psychosom Res 58 (2005) 263-269
26. Good C.D., Johnsrude I.S., Ashburner J., Henson R.N., Friston K.J., and Frackowiak R.S. A voxel-based morphometric study of ageing in 465 normal adult human brains. Neuroimage 14 1 Pt 1 (2001) 21-36
27. Gracely R.H., Petzke F., Wolf J.M., and Clauw D.J. Functional magnetic resonance imaging evidence of augmented pain processing in fibromyalgia. Arthritis Rheum 46 (2002) 1333-1343
28. Harris R.E., Clauw D.J., Scott D.J., McLean S.A., Gracely R.H., and Zubieta J.K. Decreased central mu-opioid receptor availability in fibromyalgia. J Neurosci 27 (2007) 10000-10006
29. Jackson M.E., Frost A.S., and Moghaddam B. Stimulation of prefrontal cortex at physiologically relevant frequencies inhibits dopamine release in the nucleus accumbens. J Neurochem 78 (2001) 920-923
30. Jain A.K., Carruthers B.M., van de Sande M.I., Barron S.R., Donaldson C.C.S., Dunne J.V., Gingrich E., Heffez D.S., Leung F.Y., Malone D.G., Romano T.J., Russell I.J., Saul D., and Seibel D.G. Fibromyalgia Syndrome: Canadian Clinical Working Case Definition, Diagnostic and Treatment Protocols: A Consensus Document. J Musculoskel Pain 11 (2004) 3-107
31. Kuchinad A., Schweinhardt P., Seminowicz D.A., Wood P.B., Chizh B.A., and Bushnell M.C. Accelerated brain gray matter loss in fibromyalgia patients: Premature aging of the brain?. J Neurosci 27 (2007) 4004-4007
32. Kwiatek R., Barnden L., Tedman R., Jarrett R., Chew J., Rowe C., and Pile K. Regional cerebral blood flow in fibromyalgia: Single-photon-emission computed tomography evidence of reduction in the pontine tegmentum and thalami. Arthritis Rheum 43 (2000) 2823-2833
33. Lavenex P., and Amaral D.G. Hippocampal-neocortical interaction: A hierarchy of associativity. Hippocampus 10 (2000) 420-430
34. Leavitt F., and Katz R.S. Distraction as a key determinant of impaired memory in patients with fibromyalgia. J Rheumatol 33 (2006) 127-132
35. Malt E.A., Olafsson S., Aakvaag A., Lund A., and Ursin H. Altered dopamine D2 receptor function in fibromyalgia patients: A neuroendocrine study with buspirone in women with fibromyalgia compared to female population based controls. J Affect Disord 75 (2003) 77-82
36. Martinez-Lavin M. Biology and therapy of fibromyalgia: Stress, the stress response system, and fibromyalgia. Arthritis Res Ther 9 (2007) 216
37. Matsuda H. The role of neuroimaging in mild cognitive impairment. Neuropathology 27 (2007) 567-570
38. May A. Chronic pain may change the structure of the brain. Pain 137 (2008) 7-15
39. May A., Ashburner J., Büchel C., McGonigle D.J., Friston K.J., Frackowiak R.S., and Goadsby P.J. Correlation between structural and functional changes in brain in an idiopathic headache syndrome. Nat Med 5 (1999) 836-838
40. McLean S.A., Williams D.A., Stein P.K., Harris R.E., Lyden A.K., Whalen G., Park K.M., Liberzon I., Sen A., Gracely R.H., Baraniuk J.N., and Clauw D.J. Cerebrospinal fluid corticotropin-releasing factor concentration is associated with pain but not fatigue symptoms in patients with fibromyalgia. Neuropsychopharmacology 31 (2006) 2776-2782
41. Mosconi L. Brain glucose metabolism in the early and specific diagnosis of Alzheimer's disease: FDG-PET studies in MCI and AD. Eur J Nucl Med Mol Imaging 32 (2005) 486-510
42. Mountz J.M., Bradley L.A., Modell J.G., Alexander R.W., Triana-Alexander M., Aaron L.A., Stewart K.E., Alarcón G.S., and Mountz J.D. Fibromyalgia in women: Abnormalities of regional cerebral blood flow in the thalamus and the caudate nucleus are associated with low pain threshold levels. Arthritis Rheum 38 (1995) 926-938
43. Nagano-Saito A., Washimi Y., Arahata Y., Kachi T., Lerch J.P., Evans A.C., Dagher A., and Ito K. Cerebral atrophy and its relation to cognitive impairment in Parkinson disease. Neurology 64 (2005) 224-249
44. Okada T., Tanaka M., Kuratsune H., Watanabe Y., and Sadato N. Mechanisms underlying fatigue: A voxel-based morphometric study of chronic fatigue syndrome. BMC Neurol 4 (2004) 14
45. Petrou M., Harris R.E., Foerster B.R., McLean S.A., Sen A., Clauw D.J., and Sundgren P.C. Proton MR spectroscopy in the evaluation of cerebral metabolism in patients with fibromyalgia: Comparison with healthy controls and correlation with symptom severity. AJNR Am J Neuroradiol 29 (2008) 913-918
46. Peyron R., Laurent B., and García-Larrea L. Functional imaging of brain responses to pain: A review and meta-analysis (2000). Neurophysiol Clin 30 (2000) 263-288
47. Porrino L.J., and Goldman-Rakic P.S. Brainstem innervation of prefrontal and anterior cingulate cortex in the rhesus monkey revealed by retrograde transport of HRP. J Comp Neurol 205 (1982) 63-76
48. Radley J.J., Sisti H.M., Hao J., Rocher A.B., McCall T., Hof P.R., McEwen B.S., and Morrison J.H. Chronic behavioral stress induces apical dendritic reorganization in pyramidal neurons of the medial prefrontal cortex. Neuroscience 125 (2004) 1-6
49. Rainville P., Duncan G.H., Price D.D., Carrier B., and Bushnell M.C. Pain affect encoded in human anterior cingulate but not somatosensory cortex. Science 277 (1997) 968-971
50. Schmidt-Wilcke T. Variations in brain volume and regional morphology associated with chronic pain. Curr Rheumatol Rep 10 (2008) 467-474
51. Schmidt-Wilcke T., Leinisch E., Gänssbauer S., Draganski B., Bogdahn U., Altmeppen J., and May A. Affective components and intensity of pain correlate with structural differences in gray matter in chronic back pain patients. Pain 125 (2006) 89-97
52. Schmidt-Wilcke T., Leinisch E., Straube A., Kämpfe N., Draganski B., Diener H.C., Bogdahn U., and May A. Gray matter decrease in patients with chronic tension type headache. Neurology 65 (2005) 1483-1486
53. Schmidt-Wilcke T., Luerding R., Weigand T., Jürgens T., Schuierer G., Leinisch E., and Bogdahn U. Striatal gray matter increase in patients suffering from fibromyalgia: A voxel-based morphometry study. Pain 132 Suppl 1 (2007) S109-S116
54. Schweinhardt P., Sauro K.M., and Bushnell M.C. Fibromyalgia: a disorder of the brain?. Neuroscientist 14 (2008) 415-421
55. Sephton S.E., Studts J.L., Hoover K., Weissbecker I., Lynch G., Ho I., McGuffin S., and Salmon P. Biological and psychological factors associated with memory function in fibromyalgia syndrome. Health Psychol 22 (2003) 592-597
56. Sheehan D.V., Lecrubier Y., Sheehan K.H., Amorim P., Janavs J., Weiller E., Hergueta T., Baker R., and Dunbar G.C. The Mini-International Neuropsychiatric Interview (M.I.N.I.): The development and validation of a structured diagnostic psychiatric interview for DSM-IV and ICD-10. J Clin Psychiatry 59 Suppl 20 (1998) 22-33
57. Simpson R, Glabus MF, Patterson JC,Wood PB: Is reduced dopamine availability the catalyst for grey matter changes in fibromyalgia syndrome? Program No. 488.11. 2006 Neuroscience Meeting Planner. Atlanta, GA, Society for Neuroscience, 2006. Available at: http://www.sfn.org/am2006/
58. Staud R., Price D.D., Robinson M.E., and Vierck Jr. C.J. Body pain area and pain-related negative affect predict clinical pain intensity in patients with fibromyalgia. J Pain 5 (2004) 338-343
59. Thieme K., and Turk D.C. Heterogeneity of psychophysiological stress responses in fibromyalgia syndrome patients. Arthritis Res Ther 8 (2006) R9
60. Tisserand D.J., van Boxtel M.P., Pruessner J.C., Hofman P., Evans A.C., and Jolles J. A voxel-based morphometric study to determine individual differences in gray matter density associated with age and cognitive change over time. Cereb Cortex 14 (2004) 966-973
61. Uno H., Tarara R., Else J.G., Suleman M.A., and Sapolsky R.M. Hippocampal damage associated with prolonged and fatal stress in primates. J Neurosci 9 (1989) 1705-1711
62. Villarreal G., Hamilton D.A., Petropoulos H., Driscoll I., Rowland L.M., Griego J.A., Kodituwakku P.W., Hart B.L., Escalona R., and Brooks W.M. Reduced hippocampal volume and total white matter volume in posttraumatic stress disorder. Biol Psychiatry 52 (2002) 119-125
63. Westerink B.H., Enrico P., Feimann J., and De Vries J.B. The pharmacology of mesocortical dopamine neurons: A dual-probe microdialysis study in the ventral tegmental area and prefrontal cortex of the rat brain. J Pharmacol Exp Ther 285 (1998) 143-154
64. Wolfe F., Smythe H.A., Yunus M.B., Bennett R.M., Bombardier C., Goldenberg D.L., Tugwell P., Campbell S.M., Abeles M., Clark P., Fam A.G., Farber S.J., Fiechtner J.J., Franklin C.M., Gatter R.A., Hamaty D., Lessard J., Lichtbroun A.S., Masi A.T., McCain G.A., Reynolds W.J., Romano T.J., Russell I.J., and Sheon R.P. The American College of Rheumatology 1990 Criteria for the Classification of Fibromyalgia: Report of the Multicenter Criteria Committee. Arthritis Rheum 33 (1990) 160-172
65. Wood P.B. Neuroimaging in functional somatic syndromes. Int Rev Neurobiol 67 (2005) 119-163
66. Wood P.B., Ledbetter CR., Glabus M.F., Broadwell L.K., and Patterson II J.p. Hippocampal metabolite abnormalities in fibromyalgia: Correlation with clinical features. J Pain 10 (2009) 47-52
67. Wood P.B., Patterson II J.C., Sunderland J.J., Tainter K.H., Glabus M.F., and Lilien D.L. Reduced presynaptic dopamine activity in fibromyalgia syndrome demonstrated with positron emission tomography: A pilot study. J Pain 8 (2007) 51-58
68. Wood P.B., Schweinhardt P., Jaeger E., Dagher A., Hakyemez H., Rabiner E.A., Bushnell M.C., and Chizh B.A. Fibromyalgia patients show an abnormal dopamine response to pain. Eur J Neurosci 25 (2007) 3576-3582